Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to ...

Johnson & Johnson is suing a former oncology medical affairs employee, alleging a massive and “malicious” stealing of trade secrets.  | Johnson & Johnson is suing a former oncology medical affairs ...

Erda-iDRS delivers erdafitinib into the bladder over three months, enabling localised therapy and reducing systemic exposure.

A California judge threw out a jury’s award directing Johnson & Johnson to pay ​nearly a billion dollars in punitive damages to the family of a woman who died from mesothelioma, a ‌cancer they said ...

Breaking up isn’t so hard to do, after all. Just two years after spinning off its consumer products as Kenvue Inc., Johnson & Johnson aims to part ways with its orthopedics unit, which will take with ...